Viewing Study NCT05375903


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-26 @ 11:47 AM
Study NCT ID: NCT05375903
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-14
First Post: 2022-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Sponsor: UroGen Pharma Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module